Underpinning the Transformative Potential of Spatial Omics in Toxicologic Pathology

Time: 4:45 pm
day: Day One

Details:

• Considering the preanalytical variables that can influence the quality and reproducibility of spatial omics data
• Exploring how spatial omics can be applied effectively in preclinical species to generate meaningful insights
• Highlighting the vital role of pathologists in designing, conducting, and interpreting spatial omics experiments

Speakers:

Chandra Saravanan Chandra Saravanan is a board-certified Veterinary Pathologist working at Novartis Biomedical Research, Cambridge, MA. At Novartis, he supports investigative and regulatory toxicological studies for the Read more